Radiotherapy for bone metastases of hepatocellular carcinoma: a hybrid systematic review with meta-analyses

References

• Apisarnthanarax S, Barry A, Cao M, Czito B, DeMatteo R, Drinane M, Hallemeier CL, Koay EJ, Lasley F, Meyer J, et al. 2022. External beam radiation therapy for primary liver cancers: an ASTRO clinical practice guideline. Practical Radiation Oncology. 12(1):28–51.
   PubMed Web of Science ®Google Scholar
• Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, Hartmann-Boyce J, Ryan R, Shepperd S, Thomas J, et al. 2020. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 368:l6890.
   PubMed Web of Science ®Google Scholar
• Chang U-K, Kim M-S, Han CJ, Lee DH. 2014. Clinical result of stereotactic radiosurgery for spinal metastasis from hepatocellular carcinoma: comparison with conventional radiation therapy. J Neurooncol. 119(1):141–148.
   PubMed Web of Science ®Google Scholar
• Chen H-y, Ma X-m, Bai Y-r. 2012. Radiographic characteristics of bone metastases from hepatocellular carcinoma. Contemp Oncol. 16(5):424–431.
   Google Scholar
• Chen J, Lu S, Zhang Y, Xu L, Chen J, Wang J, Chen M, Zhang R, Zhou Z. 2018. Sorafenib monotherapy versus sorafenib combined with regional therapies for hepatocellular carcinoma patients with pulmonary oligometastases: a propensity score-matched analysis. J Cancer. 9(10):1745–1753.
   PubMed Web of Science ®Google Scholar
• Cheng A-L, Guan Z, Chen Z, Tsao C-J, Qin S, Kim JS, Yang T-S, Tak WY, Pan H, Yu S, et al. 2012. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia–Pacific trial. Eur J Cancer. 48(10):1452–1465.
   PubMed Web of Science ®Google Scholar
• Cheng A-L, Kang Y-K, Chen Z, Tsao C-J, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang T-S, et al. 2009. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 10(1):25–34.
   PubMed Web of Science ®Google Scholar
• Cho H, Oh J, Han I, Kim H-S. 2009. Survival of patients with skeletal metastases from hepatocellular carcinoma after surgical management. J Bone Joint Surg Br. 91(11):1505–1512.
   PubMedGoogle Scholar
• Choe J, Lee H, Rim C. 2022. in press. Will the collaboration of surgery and external radiotherapy open new avenues for hepatocellular carcinoma with portal vein thrombosis? WJG. 28(7):704–714.
   PubMed Web of Science ®Google Scholar
• Cochran WG. 1954. The combination of estimates from different experiments. Biometrics. 10(1):101–129.
   Web of Science ®Google Scholar
• Duval S, Tweedie R. 2000. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 56(2):455–463.
   PubMed Web of Science ®Google Scholar
• Eden J, Levit L, Berg A, Morton S. 2011. Committee on Standards for systematic reviews of comparative effectiveness research; Institute of Medicine. Finding what works in health care: standards for systematic reviews. Washington, DC: The National Academies Press.
   Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim T-Y, Kudo M, Breder V, Merle P, Kaseb AO, et al. 2020. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 382(20):1894–1905.
   PubMed Web of Science ®Google Scholar
• Greenhalgh T, Thorne S, Malterud K. 2018. Time to challenge the spurious hierarchy of systematic over narrative reviews? Eur J Clin Invest. 48(6):e12931-e12931.
   Web of Science ®Google Scholar
• Habermehl D, Haase K, Rieken S, Debus J, Combs SE. 2011. Defining the role of palliative radiotherapy in bone metastasis from primary liver cancer: an analysis of survival and treatment efficacy. Tumori J. 97(5):609–613.
   PubMed Web of Science ®Google Scholar
• Halperin EC, Brady LW, Wazer DE, Perez CA. 2013. Perez & Brady's principles and practice of radiation oncology. Pennsylvania, Philadelphia: Lippincott Williams & Wilkins.
   Google Scholar
• Harada H, Nishimura T, Kamata M, Asakura H, Zenda S, Takahashi M, Katagiri H, Takagi T. 2006. Radiotherapy for bone metastases from hepatocellular carcinoma and pancreas cancer. Gan to Kagaku Ryoho. 33(8):1061–1064.
   PubMedGoogle Scholar
• Hayashi S, Tanaka H, Hoshi H. 2014. External beam radiotherapy for painful bone metastases from hepatocellular carcinoma: multiple fractions compared with an 8-Gy single fraction. Nagoya J Med Sci. 76(1–2):91.
   PubMed Web of Science ®Google Scholar
• He J, Shi S, Ye L, Ma G, Pan X, Huang Y, Zeng Z. 2019. A randomized trial of conventional fraction versus hypofraction radiotherapy for bone metastases from hepatocellular carcinoma. J Cancer. 10(17):4031–4037.
   PubMed Web of Science ®Google Scholar
• He J, Zeng Z-C, Tang Z-Y, Fan J, Zhou J, Zeng M-S, Wang J-H, Sun J, Chen B, Yang P, et al. 2009. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer. 115(12):2710–2720.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG. 2002. Quantifying heterogeneity in a meta-analysis. Stat Med. 21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Ho C-L, Chen S, Cheng TKC, Leung YL. 2011. PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma. Radiology. 258(2):515–523.
   PubMed Web of Science ®Google Scholar
• Huggins JPT, Thomas J, Chandler J, Cumpston M, Li T. Cochrane Handbook for Systematic Reviews of Interventions version 6.2. Cochrane, 2021 [accessed February 2021]. www.training.cochrane.org/handbook.
   Google Scholar
• Huggins JPT, Thomas J, Chandler J, Cumpston M, Li T. Tools for assessing methodological quality or risk of bias in non-randomized studies; Cochrane Handbook for Systematic Reviews of Interventions version 6.2. Cochrane, 2021 [accessed February 2021]. www.training.cochrane.org/handbook.
   Google Scholar
• Jung I-H, Yoon SM, Kwak J, Park J-H, Song SY, Lee S-W, Do Ahn S, Choi EK, Kim JH. 2017. High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma. Oncotarget. 8(9):15182–15192.
   PubMedGoogle Scholar
• Kaizu T, Karasawa K, Tanaka Y, Matuda T, Kurosaki H, Tanaka S, Kumazaki T. 1998. Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients. Am J Gastroenterol. 93(11):2167–2171.
   PubMed Web of Science ®Google Scholar
• Katamura Y, Aikata H, Hashimoto Y, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, et al. 2010. Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma. Hepatol Res. 40(12):1195–1203.
   PubMed Web of Science ®Google Scholar
• Kato H, Yoshida H, Taniguch H, Nomura R, Sato K, Suzuki I, Nakata R. 2015. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma. WJG. 21(46):13101.
   PubMed Web of Science ®Google Scholar
• Kim S, Choi Y, Kwak D-W, Lee HS, Hur W-J, Baek YH, Lee SW. 2019. Prognostic factors in hepatocellular carcinoma patients with bone metastases. Radiat Oncol J. 37(3):207–214.
   PubMed Web of Science ®Google Scholar
• Kim S, Chun M, Wang H, Cho S, Oh Y-T, Kang S-H, Yang J. 2007. Bone metastasis from primary hepatocellular carcinoma: characteristics of soft tissue formation. Cancer Res Treat. 39(3):104–108.
   PubMedGoogle Scholar
• Kim T, Cha HJ, Kim JW, Seong J, Lee IJ. 2016. High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma. Oncotarget. 7(33):53921–53929.
   PubMedGoogle Scholar
• Kim TH, Park S, Rim CH, Choi C, Seong J. 2021. Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma. J Cancer Res Clin Oncol. 147(9):2693–2698.
   PubMed Web of Science ®Google Scholar
• Kim UB, Doo CJ, Baek SH, Kim JH, Lee HB, Park SK, Byun JH. 1989. Natural history and prognostic factors of primary hepatocellular carcinoma: study of 70 untreated patients. Korean J Intern Med. 4(2):136–141.
   PubMedGoogle Scholar
• Kudo M, Izumi N, Sakamoto M, Matsuyama Y, Ichida T, Nakashima O, Matsui O, Ku Y, Kokudo N, Makuuchi M, Liver Cancer Study Group of Japan 2016. Survival analysis over 28 years of 173,378 patients with hepatocellular carcinoma in Japan. Liver Cancer. 5(3):190–197.
   PubMed Web of Science ®Google Scholar
• Lee H, Park S, Seo Y, Yoon W, Rim C, on behalf of the Korean Liver Cancer Study Group. 2021. Benefits of local treatment including external radiotherapy for hepatocellular carcinoma with portal invasion. Biology. 10(4):326.
   PubMedGoogle Scholar
• Lee JH, Kim HY, Kim YJ, Yoon JH, Chung JW, Lee HS. 2015. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area. J Gastroenterol Hepatol. 30(4):696–705.
   PubMed Web of Science ®Google Scholar
• Liver EAfTSot. 2018. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology. 69(2):406–460.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J-F, de Oliveira AC, Santoro A, Raoul J-L, Forner A, et al. 2008. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 359(4):378–390.
   PubMed Web of Science ®Google Scholar
• Matsuura M, Nakajima N, Ito K. 1998. Radiation therapy for bone metastasis of hepatocellular carcinoma. Int J Clin Oncol. 3(1):31–35.
   Google Scholar
• Pan T, Xie Q-K, Lv N, Li X-S, Mu L-W, Wu P-H, Zhao M. 2017. Percutaneous CT-guided radiofrequency ablation for lymph node oligometastases from hepatocellular carcinoma: a propensity score–matching analysis. Radiology. 282(1):259–270.
   PubMed Web of Science ®Google Scholar
• Park HC, Seong J, Han KH, Chon CY, Moon YM, Suh CO. 2002. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 54(1):150–155.
   PubMed Web of Science ®Google Scholar
• Park S, Byun HK, Seong J. 2019. Irradiation-related lymphopenia for bone metastasis from hepatocellular carcinoma. Liver Cancer. 8(6):468–479.
   PubMed Web of Science ®Google Scholar
• Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt YZ. 1998. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol. 21(4):386–391.
   PubMed Web of Science ®Google Scholar
• Peterson J, Welch V, Losos M, Tugwell P. 2011. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [accessed 1 October 2021]. Available at: https://www.ohri.ca//programs/clinical_epidemiology/oxford.Asp
   Google Scholar
• Rich SE, Chow R, Raman SL, Zeng K, Lutz S, Lam H, Silva MF, Chow E. 2018. Update of the systematic review of palliative radiation therapy fractionation for bone metastases. Radiother Oncol. 126(3):547–557.
   PubMed Web of Science ®Google Scholar
• Rim CH, Cheng J, Huang W-Y, Kimura T, Lee V, Zeng Z-C, Seong J. 2020. An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective. Radiotherapy and Oncology. 148:73–81.
   PubMed Web of Science ®Google Scholar
• Rim CH, Shin I-S, Park S, Lee HY. 2021. Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review. NPJ Precis Oncol. 5(1):2–13.
   PubMed Web of Science ®Google Scholar
• Rim CH, Yim HJ, Park S, Seong J. 2019. Recent clinical applications of external beam radiotherapy for hepatocellular carcinoma according to guidelines, major trials and meta‐analyses. J Med Imaging Radiat Oncol. 63(6):812–821.
   PubMed Web of Science ®Google Scholar
• Rim CH, Yoon WS. 2018. Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials. Onco Targets Ther. 11:2865–2874.
   PubMed Web of Science ®Google Scholar
• Roca EL, Okazaki N, Okada S, Nose H, Aoki K, Akine Y, Egawa S. 1992. Radiotherapy for bone metastases of hepatocellular carcinoma. Jpn J Clin Oncol. 22(2):113–116.
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Maebayashi T, Aizawa T, Ishibashi N, Fukushima S, Saito T. 2016. Radiation therapy and palliative care prolongs the survival of hepatocellular carcinoma patients with bone metastases. Intern Med. 55(9):1077–1083.
   PubMed Web of Science ®Google Scholar
• Santini D, Pantano F, Riccardi F, Di Costanzo GG, Addeo R, Guida FM, Ceruso MS, Barni S, Bertocchi P, Marinelli S, et al. 2014. Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey. PLOS One. 9(8):e105268.
   PubMed Web of Science ®Google Scholar
• Shin I-S, Rim CH. 2021. Updating perspectives on meta-analyses in the field of radiation oncology. Medicina. 57(2):117.
   PubMedGoogle Scholar
• Sohn S, Chung CK, Sohn MJ, Kim SH, Kim J, Park E. 2016. Radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from hepatocellular carcinoma: a multicenter, matched-pair study. J Korean Neurosurg Soc. 59(1):37–43.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 283(15):2008–2012.
   PubMed Web of Science ®Google Scholar
• Wang M, Wang Y, Feng X, Wang R, Wang Y, Zeng H, Qi J, Zhao H, Li N, Cai J, et al. 2017. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: experience of the Chinese National Cancer Center. Int J Infect Dis. 65:15–21.
   PubMed Web of Science ®Google Scholar
• Weichselbaum RR, Hellman S. 2011. Oligometastases revisited. Nat Rev Clin Oncol. 8(6):378–382.
   PubMed Web of Science ®Google Scholar
• Yeung YP, Lo CM, Liu CL, Wong BC, Fan ST, Wong J. 2005. Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterology. 100(9):1995–2004.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shi H, Li B, Cai L, Gu Y, Xiu Y. 2015. The added value of SPECT/spiral CT in patients with equivocal bony metastasis from hepatocellular carcinoma. Nuklearmedizin. 54(06):255–261.
   PubMedGoogle Scholar
• Zhu RX, Seto WK, Lai CL, Yuen MF. 2016. Epidemiology of hepatocellular carcinoma in the Asia-Pacific Region. Gut Liver. 10(3):332–339.
   PubMed Web of Science ®Google Scholar
• Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM. 2015. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology. 149(5):1226–1239.e1224.
   PubMed Web of Science ®Google Scholar